Kratom 消费 - 三名患者的故事
Samantha A Gnanasegaram1, Lauren Sexton2, Corneliu N Stanciu3,4
1Department of Psychiatry, Hope Counseling, Pittsfield, NH, USA.
Journal of psychoactive drugs
|November 4, 2024
概括
医疗保健专业人员面临着越来越多的kratom使用和Kratom使用障碍 (KUD). 个性化治疗至关重要,考虑到各种动机和并发症,以有效管理.
科学领域:
- 成 药物 药物 药物 药物
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在美国,Kratom的使用正在增加,导致医疗保健提供者与更多患者接触.
- 克拉使用障碍 (KUD) 在临床环境中提出了独特的挑战.
- 不同的患者对 kratom 消费的动机需要不同的治疗策略.
研究的目的:
- 介绍一系列案例,说明管理 kratom 消费和 KUD 的复杂性.
- 突出需要个性化治疗方法在克拉依赖的患者.
- 根据患者的个人资料和动机,探索不同的治疗方式.
主要方法:
- 案例系列审查了三个不同的患者与 kratom 使用的接触.
- 详细的临床病史,治疗干预措施和每个病例的结果.
- 分析影响治疗成功的因素,包括使用动机和并发症.
主要成果:
- 案例1:从能源消耗向类似阿片类药物依赖的进展,在纳尔特雷克松挑战后需要布普伦诺芬诱导.
- 案例2:在住院患者中用甲和克洛尼丁成功排毒,随后进行纳尔特雷克松维护.
- 案例3:在没有先前成史的个体中使用Kratom治疗疼痛/焦虑,不符合KUD标准.
结论:
- 管理kratom使用和KUD需要量身定制,个性化的治疗计划.
- 患者的动机,精神病状况和治疗反应是成功管理的关键因素.
- 对有效的kratom使用障碍治疗的进一步研究是有必要的.
相关概念视频
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202


